Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-05

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's Original Abbreviated New Drug Application for Carbidopa and Levodopa (generic). The product is indicated for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)